Zenas BioPharma (NASDAQ: ZBIO) revises cash bonus incentive plan
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Zenas BioPharma, Inc. has amended and restated its Short-Term Incentive Plan, an annual discretionary cash bonus program effective January 1, 2026. The plan allows eligible full- and part-time employees to earn bonuses based on company performance and individual achievement of agreed goals.
The Board of Directors or its committee administers the plan for executives, while the Chief Executive Officer and executive leadership team oversee it for other employees. Awards are subject to Board or administrator approval, must be paid no later than March 15 following each calendar year, require employment through the payment date, and are subject to the company’s incentive compensation recoupment policies.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 5.02, 9.01
2 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
FAQ
What did Zenas BioPharma (ZBIO) change in its short-term incentive plan?
Zenas BioPharma amended and restated its Short-Term Incentive Plan, creating an annual discretionary cash bonus program. Eligible employees can receive bonuses based on company performance and individual goal achievement, with awards subject to approval by the Board or designated administrators each year.
Who is eligible for Zenas BioPharma’s amended Short-Term Incentive Plan?
The amended Short-Term Incentive Plan covers regular full- and part-time employees of Zenas BioPharma and its subsidiaries. Eligibility is determined by the plan’s administrator, which can set criteria and award forms, and decide in its sole discretion which employees participate and how awards are structured.
How are bonuses determined under Zenas BioPharma’s updated STI Plan?
Bonuses under the updated STI Plan are discretionary and based on company performance plus individual achievement of established goals and objectives. The Board or its committee determines awards for executives, while the CEO and executive leadership team oversee decisions for other eligible employees each year.
When are payments made under Zenas BioPharma’s Short-Term Incentive Plan?
Payments under the Short-Term Incentive Plan must be made no later than March 15 following the end of the applicable calendar year. Participants are required to remain employed through the actual payment date to be eligible to receive any bonus awarded under the plan.
Are Zenas BioPharma’s STI Plan awards subject to clawback or recoupment?
Yes. Awards under Zenas BioPharma’s Short-Term Incentive Plan are subject to the company’s Policy for Recoupment of Incentive Compensation and any other applicable clawback or recoupment policies, meaning bonuses can be reclaimed under specified circumstances consistent with those formal company policies.
Can Zenas BioPharma change or discontinue the amended STI Plan?
Zenas BioPharma reserves the right to amend or discontinue the Short-Term Incentive Plan at any time without prior notice. This flexibility allows the company’s Board to adjust or terminate the bonus program as needed in response to evolving business circumstances or governance decisions.